UNSPSC 51286804: Proquinolate

This classification denotes an antimicrobial with the molecular formula C17H21NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5M91328O79, chemically known as 3-quinolinecarboxylic acid, 4-hydroxy-6,7-diisopropoxy-, methyl ester but more generally known as proquinolate, which bears US NIH Compound Identifier 15547. European Medicines Agency schedules Proquinolate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10128MIG.

The term PROQUINOLATE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 21 No. 12 1967, List 7). PROQUINOLATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: O(C1C(OC(C)C)CC2[NH]CC(C(=O)C2C1)C(=O)OC)C(C)C.

UNSPSC 51286804 Proquinolate (Commodity) does not map to the state and local opportunities recently posted under this code. The recent solicitations involve naloxone procurement, direct-to-manufacturer pharmacy programs, medical and first aid supplies for emergency response, and generic pharmaceuticals for cooperative purchasing — none of which align with proquinolate, a veterinary antiprotozoal agent. State and local governments are not actively soliciting proquinolate through visible procurement channels. The code shows no relevant recent activity.

The mismatch between the code's nominal scope and the opportunities tagged to it suggests either a data classification error in the source or a code assignment that does not reflect current buying patterns. Firms evaluating activity under UNSPSC 51286804 should treat this code as dormant for state and local procurement purposes based on available evidence through July 2026.